Skip to content
Search

Latest Stories

Reeves plans increase in capital gains tax on shares: Report

Reeves is expected to maintain the current capital gains tax rate on second homes and buy-to-let properties.

Reeves plans increase in capital gains tax on shares: Report

RACHEL Reeves is expected to raise the capital gains tax rate on the sale of shares and other assets in her budget statement on 30 October. The increase for share sales is likely to be by several percentage points.

Alongside this, Reeves is anticipated to end certain reliefs in the current capital gains tax regime to boost revenues, aiming to improve public finances and avoid austerity, The Times reported on Wednesday.


While the report did not specify sources, it said that the capital gains tax on the sale of second homes would remain unchanged. However, some reliefs under the current regime are expected to be reduced to help raise more revenue.

The chancellor is expected to maintain the current capital gains tax rate on second homes and buy-to-let properties, with concerns that raising this rate could have negative financial consequences.

Currently, capital gains tax applies to profits exceeding £3,000 from the sale of assets, though self-invested personal pensions (SIPPs) and ISAs are exempt. According to The Times, there are about 12.5 million private shareholders, but only 350,000 pay this tax annually.

As the first Labour budget since the party's election in July, the October statement is under close scrutiny. It is expected to reveal who will face higher taxes and where spending cuts may be made to address the country’s financial challenges, which Labour attributes to the previous government.

Earlier, two government sources told Reuters that Reeves is considering tax rises and spending cuts worth £40 billion as part of efforts to stabilise the economy while investing in public services.

The current capital gains tax rate for higher-income taxpayers ranges between 20 per cent and 28 per cent, depending on the type of asset. For share sales, the rate is 20 per cent.

Keir Starmer, earlier this week, dismissed speculation that the capital gains tax rate would rise to 39 per cent, calling such reports unfounded.

(With inputs from Reuters)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less